[Pituitary disease: which treatment in the future?].
Even if major progress has been made in the medical treatment for pituitary adenomas in the last decades, currently available drugs do not always control hormonal secretion of these tumors. New molecules or new formulations of old drugs are under development. Pituitary stem cells research is currently also very active.
INSERM U 986, Hôpital Saint-Vincent-de-Paul, 82 avenue Denfert-Rochereau, Paris, France.
C
C
Briet
P
P
Chanson
D000236:Adenoma / Q000188:drug therapy*; D053687:Adult Stem Cells / Q000187:drug effects; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D047748:Pituitary ACTH Hypersecretion / Q000188:drug therapy; D010911:Pituitary Neoplasms / Q000188:drug therapy*; D051381:Rats; D055748:SOXB1 Transcription Factors / Q000378:metabolism; D016896:Treatment Outcome
D000970:Antineoplastic Agents; C527782:SOX2 protein, human; D055748:SOXB1 Transcription Factors; C527784:Sox2 protein, rat